|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
APTX
|
Aptinyx Inc.
|
US
|
NASDAQ
|
|
CAPR
|
Capricor Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CBAY
|
CymaBay Therapeutics Inc.
|
US
|
NASDAQ
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FMTX
|
Forma Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
LPTX
|
LEAP THERAPEUTICS, INC.
|
US
|
NASDAQ
|
|
PRQR
|
ProQR Therapeutics B.V.
|
US
|
NASDAQ
|
|
RGLS
|
Regulus Therapeutics Inc.
|
US
|
NASDAQ
|
|
SPRO
|
Spero Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LADX
|
Ladrx Corp
|
US
|
OTC
|
|
0GT
|
STOKE THERAPEUT.DL-001
|
DE
|
F
|
|
1GDA
|
KEMPHARM INC. DL-0001
|
DE
|
F
|
|
7RG0
|
REGULUS THER.COMPAR DL001
|
DE
|
F
|